Table 1 Details of cases and controls in the training and validation sets.

From: Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients

  

Age

Creatinine (g/L)

LYVE1 (ng/mL)

REG1B (ng/mL)

TFF1 (ng/mL)

Healthy samples

Training set (n = 95): mean (sd)

56.495 (12.095)

0.73 (0.543)

1.196 (1.994)

43.271 (72.339)

135.779 (224.582)

Testing set (n = 85): mean (sd)

56.518 (12.121)

0.851 (0.574)

1.231 (1.871)

38.855 (49.385)

193.749 (325.936)

p value

0.999

0.107

0.444

0.616

0.11

PDAC samples

Training set (n = 96): mean (sd)

66.271 (9.934)

0.94 (0.678)

5.542 (3.662)

216.731 (262.845)

1124.184 (1158.383)

Testing set (n = 103): mean (sd)

66.097 (11.066)

0.894 (0.767)

6.019 (3.891)

235.235 (290.935)

1171.382 (1641.401)

p value

0.979

0.244

0.395

0.674

0.773

Back to article page